Review on development of potential inhibitors of SARS-CoV-2 main protease (M(Pro))

BACKGROUND: The etiological agent for the coronavirus illness outbreak in 2019–2020 is a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), whereas coronavirus disease pandemic of 2019 (COVID-19) has compelled the implementation of novel therapeutic o...

Descripción completa

Detalles Bibliográficos
Autores principales: Katre, Soumya Gulab, Asnani, Alpana Jagdish, Pratyush, Kumar, Sakharkar, Nilima Gangadhar, Bhope, Ashwini Gajanan, Sawarkar, Kanchan Tekram, Nimbekar, Vaibhav Santosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209839/
https://www.ncbi.nlm.nih.gov/pubmed/35756354
http://dx.doi.org/10.1186/s43094-022-00423-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209839/
https://www.ncbi.nlm.nih.gov/pubmed/35756354
http://dx.doi.org/10.1186/s43094-022-00423-7

Ejemplares similares